D-0663-2026 Class II Ongoing

Recalled by BioMed Laboratories, LLC. — Dallas, TX

FDA drug recall D-0663-2026 was initiated by BioMed Laboratories, LLC. on Jun 11, 2026 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification. The recall status is ongoing. Affected quantity: 509,652 tubes.

Recall details

Product Type
Drugs
Report Date
Jul 15, 2026
Initiation Date
Jun 11, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
509,652 tubes

Product description

Medline Remedy Specialized Silicone Cream (Hydraguard-D ),Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 80090 2 FL OZ (59 mL) NDC 53329-159-13 4 FL OZ (118 mL) NDC 53329-159-04

Reason for recall

Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification.

Distribution pattern

Nationwide in the US

Code information

Lots 0001882643, 0001887165, 0001888441, 0001900835, 0001931329 & 0001951664 May 2026 Lots 0001882644, 0001899186, 0001903516, 0001905970, 0001911902, 0001917707 & 0001920638 June 2026 Lot 0001927080 Oct 2026 Lots 0001937896, 0001952194 & 0001962232, Jan-2027 Lots 0001981964, 0001981965, 0001994680 & 002012768, May 2027 Lot 0001998027, Jun 2027 Lot 002012787, Aug 2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0663-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0663-2026. Report a data issue: hello@regdatalab.com.